Abstract: Glutathione peroxidase 4 (GPX4) is a primary inhibitor of ferroptosis, a regulated form of cell death driven by the accumulation of lipid hydroperoxides. GPX4 exists in three isoforms localized in the cytosol, mitochondria, and nucleus; however, the regulatory mechanisms governing nuclear GPX4 (nGPX4) remain largely unclear. Herein, we identified TATA box-binding protein-associated factor 1 (TAF1) as a pivotal regulator of nGPX4. TAF1 phosphorylates nGPX4, leading to its lysine 11 (K11)-linked ubiquitination and proteasomal degradation, thereby promoting ferroptosis in tumor protein p53 (TP53)-mutant cells. Conversely, in TP53-wild-type (WT) cells, TAF1 phosphorylates TP53, facilitating murine double minute 2 (MDM2)-mediated TP53 degradation, which upregulates solute carrier family 7 member 11 (SLC7A11) expression and reduces cellular susceptibility to ferroptosis. Collectively, TAF1 plays dual and context-dependent roles in ferroptosis regulation, acting as both a promoter and an inhibitor depending on the TP53 status.

TAF1通过促进核GPX4的泛素化降解加剧铁死亡

[1]AkogluH, 2018. User’s guide to correlation coefficients. Turk J Emerg Med, 18(3):91-93.

[2]AneichykT, HendriksWT, YadavR, et al., 2018. Dissecting the causal mechanism of X-linked dystonia-parkinsonism by integrating genome and transcriptome assembly. Cell, 172(5):897-909.e21.

[3]BersukerK, HendricksJM, LiZP, et al., 2019. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575(7784):688-692.

[4]CheffDM, HuangCY, ScholzenKC, et al., 2023. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol, 62:102703.

[5]ChenX, KangR, KroemerG, et al., 2021. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol, 18(5):280-296.

[6]ChengHY, CapponiS, WakelingE, et al., 2020. Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity. Hum Mutat, 41(2):449-464.

[7]DengF, ZhaoBC, YangX, et al., 2021. The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes, 13(1):1902719.

[8]DibraD, XiongSB, MoyerSM, et al., 2024. Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv, 10(7):eadk1835.

[9]DiksteinR, RuppertS, TjianR, 1996. TAF_II250 is a bipartite protein kinase that phosphorylates the basal transcription factor RAP74. Cell, 84(5):781-790.

[10]DixonSJ, LembergKM, LamprechtMR, et al., 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149(5):1060-1072.

[11]DixonSJ, PatelDN, WelschM, et al., 2014. Pharmacological inhibition of cystine‒glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife, 3:e02523.

[12]DollS, FreitasFP, ShahR, et al., 2019. FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 575(7784):693-698.

[13]FengZW, YangCF, XiaoHF, et al., 2024. YTHDC1 regulates the migration, invasion, proliferation, and apoptosis of rheumatoid fibroblast-like synoviocytes. Front Immunol, 15:1440398.

[14]GoldmanMJ, CraftB, HastieM, et al., 2020. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol, 38(6):675-678.

[15]GuoYY, LiangNN, ZhangXY, et al., 2024. Mitochondrial GPX4 acetylation is involved in cadmium-induced renal cell ferroptosis. Redox Biol, 73:103179.

[16]HouW, XieYC, SongXX, et al., 2016. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy, 12(8):1425-1428.

[17]JanakiramanU, DhanalakshmiC, YuJ, et al., 2020. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome. Neurobiol Dis, 143:105006.

[18]JiangL, KonN, LiTY, et al., 2015. Ferroptosis as a p53-mediated activity during tumour suppression. Nature, 520(7545):57-62.

[19]KangYJ, PanLJ, LiuYY, et al., 2025. GEPIA3: enhanced drug sensitivity and interaction network analysis for cancer research. Nucleic Acids Res, 53(W1):W283-W290.

[20]LiHH, LiAG, SheppardHM, et al., 2004. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell, 13(6):867-878.

[21]LiJB, LiuJ, ZhouZ, et al., 2023. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med, 15(720):eadg3049.

[22]LinWJ, LiHH, ChangJ, et al., 2025. ZC3H13 may participate in the ferroptosis process of sepsis-induced cardiomyopathy by regulating the expression of Pnn and Rbm25. Gene, 933:148944.

[23]LiuYQ, GuW, 2022. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ, 29(5):895-910.

[24]MaoC, LiuXG, ZhangYL, et al., 2021. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature, 593(7860):586-590.

[25]MevissenTET, KomanderD, 2017. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem, 86:159-192.

[26]MistryJ, ChuguranskyS, WilliamsL, et al., 2021. Pfam: the protein families database in 2021. Nucleic Acids Res, 49(D1):D412-D419.

[27]MizzenCA, YangXJ, KokuboT, et al., 1996. The TAF_II250 subunit of TFIID has histone acetyltransferase activity. Cell, 87(7):1261-1270.

[28]NewtonK, StrasserA, KayagakiN, et al., 2024. Cell death. Cell, 187(2):235-256.

[29]OhHR, AnCH, YooNJ, et al., 2017. Frameshift mutations in the mononucleotide repeats of TAF1 and TAF1L genes in gastric and colorectal cancers with regional heterogeneity. Pathol Oncol Res, 23(1):125-130.

[30]PhamAD, SauerF, 2000. Ubiquitin-activating/conjugating activity of TAF_II250, a mediator of activation of gene expression in Drosophila. Science, 289(5488):2357-2360.

[31]PuglisiR, MaccariI, PipoloS, et al., 2012. The nuclear form of glutathione peroxidase 4 is associated with sperm nuclear matrix and is required for proper paternal chromatin decondensation at fertilization. J Cell Physiol, 227(4):1420-1427.

[32]QianB, CheL, DuZB, et al., 2023. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling. Theranostics, 13(12):4288-4302.

[33]RibeiroJR, LovascoLA, VanderhydenBC, et al., 2014. Targeting TBP-associated factors in ovarian cancer. Front Oncol, 4:45.

[34]RohJL, KimEH, JangHJ, et al., 2016. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett, 381(1):96-103.

[35]RohJL, KimEH, JangH, et al., 2017. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol, 11:254-262.

[36]SatoM, KusumiR, HamashimaS, et al., 2018. The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep, 8:968.

[37]SchoberP, BoerC, SchwarteLA, 2018. Correlation coefficients: appropriate use and interpretation. Anesth Analg, 126(5):1763-1768.

[38]SpiesJ, WaizeneggerA, BartonO, et al., 2016. Nek1 regulates Rad54 to orchestrate homologous recombination and replication fork stability. Mol Cell, 62(6):903-917.

[39]SuZY, KonN, YiJJ, et al., 2023. Specific regulation of BACH1 by the hotspot mutant p53^R175H reveals a distinct gain-of-function mechanism. Nat Cancer, 4(4):564-581.

[40]SunBH, WangXY, YeZQ, et al., 2023. Designing single-atom active sites on sp²-carbon linked covalent organic frameworks to induce bacterial ferroptosis‐like for robust anti‐infection therapy. Adv Sci, 10(13):2207507.

[41]SunXF, NiuXH, ChenRC, et al., 2016. Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology, 64(2):488-500.

[42]SunXF, ZhangQ, LinXH, et al., 2023. Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination. Cell Death Dis, 14:839.

[43]TavassoliP, WafaLA, ChengH, et al., 2010. TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains. Mol Endocrinol, 24(4):696-708.

[44]TongJ, LiDJ, MengHB, et al., 2022. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease. Acta Pharm Sin B, 12(9):3650-3666.

[45]WangH, CurranEC, HindsTR, et al., 2014. Crystal structure of a TAF1-TAF7 complex in human transcription factor IID reveals a promoter binding module. Cell Res, 24(12):1433-1444.

[46]WangHB, QiWW, ZouCY, et al., 2021. NEK1-mediated retromer trafficking promotes blood‒brain barrier integrity by regulating glucose metabolism and RIPK1 activation. Nat Commun, 12:4826.

[47]WangRP, SongSM, HaradaK, et al., 2020. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut, 69(1):18-31.

[48]WangWL, LiuY, WangZQ, et al., 2024. Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data. Sci Rep, 14:22251.

[49]WangZJ, XiaY, WangY, et al., 2023. The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma. Cell Death Dis, 14(10):695.

[50]WuZM, GengY, LuXJ, et al., 2019. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA, 116(8):2996-3005.

[51]XieXX, ChenCC, WangC, et al., 2024. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors. Redox Biol, 76:103350.

[52]XieYC, KangR, KlionskyDJ, et al., 2023. GPX4 in cell death, autophagy, and disease. Autophagy, 19(10):2621-2638.

[53]XuY, ManN, KarlD, et al., 2019. TAF1 plays a critical role in AML1-ETO driven leukemogenesis. Nat Commun, 10:4925.

[54]XueQ, YanD, ChenX, et al., 2023. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy, 19(7):1982-1996.

[55]YanB, AiYW, SunQ, et al., 2021. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell, 81(2):355-369.e10.

[56]YangLX, SongTJ, ChengQ, et al., 2019. Mutant p53 sequestration of the MDM2 acidic domain inhibits E3 ligase activity. Mol Cell Biol, 39(4):e00375-18.

[57]YangWS, SriRamaratnamR, WelschME, et al., 2014. Regulation of ferroptotic cancer cell death by GPX4. Cell, 156(1-2):317-331.

[58]YangWS, KimKJ, GaschlerMM, et al., 2016. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA, 113(34):E4966-E4975.

[59]ZangX, HeXY, XiaoCM, et al., 2024. Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. Mol Cancer, 23:207.

[60]ZhangJ, LiR, ZhangBX, et al., 2022. TAF1 promotes NSCLC cell epithelial-mesenchymal transition by transcriptionally activating TGFβ1. Biochem Biophys Res Commun, 636(Pt 2):113-118.

[61]ZhangSY, ZhongJY, GuoDN, et al., 2023. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis. J Biochem Mol Toxicol, 37(8):e23380.

[62]ZhouLX, YaoQ, MaL, et al., 2021. TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia. Transl Cancer Res, 10(12):5307-5318.